Prior UT
First author or co-first author:
11. Yin. Q. #; Luo, W. # (co-first author); Mallajosyula, V.; Bo, Y.; Guo, J.; Xie, J.; Sun, M.; Verma R.; Li, C.; Constant, C.; Wagar, L.; Li, J.; Sola, E.; Gupta, N.; Wang, C.; Kask, O.; Chen, X.; Yuan, X.; Rao, J.; Chien, Y.; Cheng, J.; Pulendran, B.; Davis, MM. “A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of Influenza and SARS-CoV-2”. Nature Materials, 2023, 22, 380-390.
Highlighted: News&Views “Immunostimulatory nanoparticles go viral” in Nature Materials, 2023, 22, 273-275”.
10. Yin, Q.; Yu, W.; Grzeskowiak, C.; Li, J.; Huang, H.; Guo, J.; Chen, L.; Wang, F.; Zhao, F.; von Boehmer, L.; Metzner, T.; Leppert, J.; Chien, Y-H.; Kuo, C.; Davis, MM. “Nanoparticle-enabled innate immune stimulation activates endogenous tumor infiltrating T cells with broad antigen specificities”, Proceedings of the National Academy of Sciences, 2021, 118 (21) e2016168118.
9. Yin, Q.; Tang, L.; Cai, K.; Yang, X.; Yin, L.; Zhang, Y.; Dobrucki, LW.; Helferich, WG.; Fan, TM.; Cheng, J. “Albumin as a “Trojan Horse” for Polymeric Nanoconjugates Transendothelial Transport across Tumor Vasculatures for Improved Cancer Targeting”, Biomaterials Science, 2018, 6, 1189–1200.
8. Yin, Q.#; Tang, L. # (co-first author); Tong, R.; Sternberg, R.; Yang, X.; Dobrucki, LW.; Borst, LB.; Kamstock, DA.; Cai, K.; Song, Z.; Helferich, WG.; Cheng, J.; Fan, TM. “Pamidronate Functionalized Doxorubicin-Polylactide Nanoconjugates for Targeted Therapy of Focal Skeletal Malignant Osteolysis”, Proceedings of the National Academy of Sciences, 2016, 113, E4601-4609.
Highlighted: NIH Director’ Blog, FierceBiotech, Noodles, EurekAlert!, Technology.org, Nanotechnology Now, Drug Discovery & Development, BioschienceTechnology, Azonano, Science Daily, Laboratory Journal, Phys.org, Nanowerk, Engineering at Illinois.
7. Azzi, J. #; Yin, Q.# (co-first author); Ohori, S.; Tang, L.; Cai, K.; Abdoli, R.; Uehara, M.; McGrath, M.; Kefaloyianni, E.; Ichimura, T.; Petr, J.; Sun, Q.; Kwon, M.; Cheng, J. ;Abdi, R. “Targeted delivery of immunomodulators to lymph nodes”, Cell Reports,2016, 15, 1202-1213.
6. Yin, Q.; Yin, L.; Wang, H.; Cheng, J. “Synthesis and biomedical applications of functional poly(α-hydroxy acids) via ring-opening polymerization of O-carboxyanhydrides”, Accounts of Chemical Research, 2015, 48, 1777-1787.
5. Tang, L.#; Yin, Q. # (co-first author); Xu, Y.; Zhou, Q.; Cai, K.; Yen, J.; Dobrucki, LW; Cheng, J.“Bioorthogonal Oxime Ligation Mediated In Vivo Cancer Targeting”, Chemical Science, 2015, 6, 2182-2186.
4. Yin, Q.; Tong, R.; Yin, L.; Fan, TM.; Cheng, J. “Anticancer Camptothecin-N-Poly(lactic acid) Nanoconjugates with Facile Hydrolysable Linker”, Polymer Chemistry, 2014, 5, 1581-1585.
3. Yin, Q.; Yap, FY.; Yin, L.; Ma, L.; Zhou, Q.; Dobrucki, LW.; Fan, TM.; Gaba, RC.; Cheng, J. “Poly(iohexol) Nanoparticles As Constrast Agents for In Vivo X-ray Computed Tomography Imaging”, Journal of American Chemical Society, 2013, 135, 13620–13623.
2. Yin, Q.; Tong, R.; Xu, Y.; Fan, TM.; Cheng, J.“Drug-Initiated Ring-Opening Polymerization of O-Carboxyanhydrides for the Synthesis of Drug-Poly(O-Carboxyanhydride) Nanoconjugate Anticancer Delivery Systems”, Biomacromolecules, 2013, 14, 920–929.
1. Li, L. #; Yin, Q.# (co-first author); Cheng, J.; Lu, Y.“Polyvalent Mesoporous Silica Nanoparticle-Aptamer Bioconjugates Target Breast Cancer Cells”, Advanced Healthcare Materials, 2012, 1, 567-572.
Co-author:
24. Luo, W.; Yin, Q. “B cell response to vaccination” Immunological Investigations, 2021, 50, 780-801.
23. Sun, S., Luo, L., Liang, W., Yin, Q., Guo, J., Rush, A. M., Lv, Z., Liang, Q., Fischbach, M. A., Sonnenburg, J. L., Dodd, D., Davis, M. M., Wang, F. “Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade”, Proceedings of the National Academy of Sciences, 2020, 117, 27509-27515.
22. Roth, G. A., Gale, E. C., Alcántara-Hernández, M., Luo, W., Axpe, E., Verma, R., Yin, Q., Yu, A.C., Hernandez, H.A., Maikawa, C.L., Smith, A. A, Davis, M.M., Pulendran,B., Idoyaga, J., Appel, E.A. “Injectable hydrogels for sustained codelivery of subunit vaccines enhance humoral immunity”, ACS central science, 2020, 6, 1800-1812.
21. Fernandes, R. A., Su, L., Nishiga, Y., Ren, J., Bhuiyan, A. M., Cheng, N., Kuo, C. J., Picton, L. K., Ohtsuki, S., Majzner, R. G., Rietberg, S. P., Mackall, C. L., Yin, Q., Ali, L. R., Yang, X., Savvides, C. S., Sage, J., Dougan, M., Garcia, K. C. “Immune receptor inhibition through enforced phosphatase recruitment”, Nature, 2020, 586, 779–784.
20. Wang, F.; Yin, Q.; Chen, L.; Davis M. M. “Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade”, Proceedings of the National Academy of Sciences, 2018, 151, 157-161.
19. Wang, H.; Wang, R.; Cai, K.; He, H.; Liu, Y.; Yen, J.; Wang, Z.; Xu, M.; Sun, Y.; Zhou, X.; Yin, Q.; Tang, L.; Dobrucki, I.T.; Dobrucki, L.W.; Chaney, E.J.; Boppart, S.A.; Fan, T.M.; Lezmi, S.; Chen, X.; Yin, L.; Cheng, J. “Selective In Vivo Metabolic Cell Labeling Mediated Cancer Targeting”, Nature Chemical Biology, 2017, 13, 415-424.
18. Wang, R.; Zhang, J.; Yin, Q.; Xu, Y.; Cheng, J.; Tong, R. “Controlled Ring-Opening Polymerization of O-Carboxyanhydrides Using β-Diiminate Zinc Catalyst”, Angew. Chem. Int. Ed., 2016, 55, 13010-13014.
17. Xing, H.; Xu, W.; Hwang, K.; Wu, P.; Yin, Q.; Li, Z.; Cheng, J.; Lu, Y. “The Effects of Spacer Length and Composition on Aptamer-Mediated Cell-Specific Targeting with Nanoscale PEGylated Liposomal Doxorubicin”, CHEMBIOCHEM, 2016, 17, 1111-1117.
16. Tang, L.; Tong, R; Coyle, V; Yin, Q; Pondenis, H; Borst, L; Cheng, J; Fan, T. “Targeting Tumor Vasculature with Aptamer Functionalized Doxorubicin-Polylactide Nanoconjugates for Enhanced Cancer Therapy”, ACS Nano, 2015, 9, 5072-5081.
15.Zhang, Y.; Yin, Q.; Yen, J.; Li, J.; Ying, H.; Wang, H.; Hua, Y.; Chaney, E.; Boppart, S.; Cheng, J. “Non-Invasive, Real-Time Reporting Drug Release In Vitro and In Vivo”, Chemical Communications, 2015, 51, 6948-6951.
14. Cai, K.; He, X.;Song, Z.; Yin, Q.; Zhang, Y.; Uckun, F.; Jiang, C.; Cheng, J. “Dimeric Drug Polymeric Nanoparticles with Exceptionally High Drug Loading and Quantitative Loading Efficiency”, Journal of American Chemical Society, 2015, 137, 3458-3461.
13. Yin, L.; Chen, Y.; Zhang, Z.; Yin, Q.; Zheng, N.; Cheng, J. “Biodegradable Micelles Capable of Mannose-Mediated Targeted Drug Delivery to Cancer Cells”, Macromolecular Rapid Communications, 2015, 36, 483-489.
12. Cai, K.; Yen, J.; Yin, Q.; Liu, Y.; Song, Z.; Lezmi, S.; Zhang, Y.; Yang, X.; Helferich, WG.; Cheng, J. “Redox-Responsive Self-Assembled Chain-Shattering Polymeric Therapeutics”, Biomaterials Science, 2015, 3, 1061-1065.
11. Gauthier, M.; Yin, Q.; Cheng, J.; O’Brien, WD. “Design of albumin-coated microbubbles loaded with polylactide nanoparticles”, J. Ultrasound Medicine, 2015, 34, 1363-1372.
10. Tang, L.; Yang, X.; Yin, Q.; Cai, K.; Wang, H.; Chaudhury, I.; Yao, C.; Zhou, Q.; Kwon, M.; Hartman, JA.; Dobrucka, IT; Dobrucki, LW; Borst, LB; Lezmi, S.; Helferich, WG.; Ferguson, AL; Fan, TM.; Cheng, J. “Investigating the optimal size of anticancer nanomedicine”, Proceedings of the National Academy of Sciences, 2014, 111, 15344-15349.
9. Zhang, Y.; Yin, Q.; Yin, L.; Ma, L.; Tang, L.; Cheng, J. “Chain-Shattering Polymeric Therapeutics with On-Demand Drug-Release Capability”, Angew Chem. Int. Ed., 2013, 52, 6435-6439.
8. Wang, H.;Tang, L.; Tu, C.; Song, Z.; Yin, Q.; Yin, L.; Zhang, Z.; Cheng, J. “Redox-Responsive, Core-Cross-Linked Micelles Capable of On-Demand, Concurrent Drug Release and Structure Disassembly ”, Biomacromolecules, 2013, 14, 3706–3712.
7. Zhang, Y.; Yin, Q.; Lu, H.; Xia, H.; Lin, Y.; Cheng, J. “PEG-Polypeptide Dual Brush Block Copolymers: Synthesis and Application in Nanoparticle Surface PEGylation”, ACS Macro Letter, 2013, 2, 809-813.
6. Xing, H.; Tang, L.; Yang, X.; Hwang, K.; Wang, W.; Yin, Q.; Dobrucki, W.; Yasui, N.; Katzenellenbogen, JA; Helferich, WG; Cheng, J.; Lu, Y. “Selective delivery of an anticancer drug with aptamer-functionalized liposomes to breast cancer cells in vitro and in vivo”, J. Mater. Chem. B, 2013, 1, 5288-5297.
5. Uckun, F.M.; Qazi, S.; Cely, I.; Sahin, K.; Shahidzadeh, A.; Jan, S.; Tuzcu, M.; Ilhan, N.; Ozercan, I.; Yin, Q.; Gaynon, P.; Termuhlen, A.; Cheng, J.; Yiv, S.H.; “Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia.”, Blood, 2013, 121, 4348-4354.
4. Tang, L.; Yang, X.; Dobrucki, LW; Chaudhury, I.; Yin, Q.; Yao, C.; Lezmi, S.; Helferich, WG Fan, TM; Cheng, J. “Apatmer-functionalized, ultra-small, monodisperse silica nanoconjugate for targeted dual-modal imaging of lymph nodes with metastatic tumors”, Angew Chem. Int. Ed., 2012, 124, 12893-12898.
3. Tang, L.; Azzi, J.; Kwon, M.; Mounayar, M.; Tong, R.; Yin, Q.; Moore, RF.; Skartsis, N.; Fan, TM.; Abdi, R.; Cheng, J.“Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A”, Journal of Transplantation, 2012, Article ID 896141.
2. Chen, K.; Tang, L.; Garcia, MA; Wang, H.; Lu, H.; Lin, WY; Hou, S.; Yin, Q.; Shen, CKF.; Cheng, J.; Tseng, HR. “The therapeutic efficacy of camptothecin-encapsulated supramolecular nanoparticles”, Biomaterials, 2012, 33, 1162-1169.
1. Cely, I.; Yiv, S.; Yin, Q.; Shahidzadeh, A.; Tang, L.; Cheng, J.; Uckun, F.M. “Targeting Mantle Cell Lymphoma with Anti-SYK Nanoparticles”, J. Anal. Oncology, 2012, 1, 1-9.
